PBH - Company ID 0001295947
The table below shows Prestige Consumer Healthcare Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943.37M |
| Cost of revenue | $493.13M | $503.30M | $500.91M | $502.43M | $466.17M | $395.89M |
| Gross profit | $595.58M | $634.46M | $624.45M | $625.29M | $620.65M | $547.47M |
| R&D | - | - | - | - | - | - |
Prestige Consumer Healthcare Inc. reported annual revenue of $1.09B for fiscal year 2026. That is down 4.3% from $1.14B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $882.06M (FY 2017) to $1.09B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $116.45M |
| $108.21M |
| $106.15M |
| $107.35M |
| $107.46M |
| $83.11M |
| Operating income | $309.41M | $336.77M | $342.43M | -$22.41M | $329.92M | $297.40M |
| Income tax | $67.19M | $69.58M | $66.69M | -$11.61M | $57.08M | $39.43M |
| Net income | $190.30M | $214.60M | $209.34M | -$82.31M | $205.38M | $164.68M |
| EPS (diluted) | $3.91 | $4.29 | $4.17 | -$1.65 | $4.04 | $3.25 |